KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,781 | +17.7% | 7,011 | -4.6% | 0.00% | – |
| Q2 2023 | $103,502 | +25.4% | 7,351 | -4.2% | 0.00% | – |
| Q1 2023 | $82,561 | -7.8% | 7,673 | +28.3% | 0.00% | – |
| Q4 2022 | $89,565 | -18.6% | 5,979 | -30.1% | 0.00% | -100.0% |
| Q3 2022 | $110,000 | +32.5% | 8,549 | 0.0% | 0.00% | – |
| Q2 2022 | $83,000 | +16.9% | 8,549 | +19.3% | 0.00% | – |
| Q1 2022 | $71,000 | -15.5% | 7,164 | 0.0% | 0.00% | – |
| Q4 2021 | $84,000 | +300.0% | 7,164 | +290.0% | 0.00% | – |
| Q3 2021 | $21,000 | -19.2% | 1,837 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -23.5% | 1,837 | 0.0% | 0.00% | – |
| Q1 2021 | $34,000 | +6.2% | 1,837 | 0.0% | 0.00% | – |
| Q4 2020 | $32,000 | +14.3% | 1,837 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | – | 1,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |